AIM: To determine rates of cerebral atrophy in individuals with symptoms of memory loss but no objective cognitive impairment (SNCI) and their association with future cognitive decline. METHODS: Thirty-two SNCI subjects, 16 with mild cognitive impairment (MCI) and 27 control subjects had clinical assessment and magnetic resonance imaging at baseline and 1 year later. Rates of whole brain atrophy (WBA), hippocampal atrophy (HA) and ventricular enlargement (VE) were measured. Our outcome was clinical diagnosis at 2 years after entry into the study. RESULTS: The MCI group had greater rates of WBA, HA and VE than both controls and SNCI subjects. As a group SNCI subjects did not have significantly greater rates of atrophy than the controls. Howe...
Background/Aims: To evaluate whether visual assessment of medial temporal lobe atrophy (vaMTA) can p...
Objectives: To investigate whether medial temporal lobe atrophy predicted outcome in patients with m...
Objective: To determine if baseline measurements of cerebral atrophy and severity of white matter hy...
OBJECTIVE: A large cohort of subjects with mild cognitive impairment (MCI) was categorized into tert...
Objective: To assess the relationship between MRI-derived changes in whole-brain and ventricular vol...
OBJECTIVE: To assess the relationship between MRI-derived changes in whole-brain and ventricular vol...
OBJECTIVE: To identify cognitively normal individuals at risk of Alzheimer disease (AD) based on cer...
BACKGROUND: Symptoms of memory loss are a common complaint within the general population and a frequ...
Background: Individuals diagnosed as having mild cognitive impairment (MCI) have a high likelihood o...
Objective: To estimate rates of progression from mild cognitive impairment (MCI) to dementia and of ...
Objectives: To investigate the association between cognitive decline and cortical atrophy in individ...
OBJECTIVE: To quantify the regional and global cerebral atrophy rates and assess acceleration rates ...
Objective: Mild behavioral impairment (MBI) is a neurobehavioral syndrome characterized by later lif...
Background: While acceleration in age-related cerebral atrophy has been well documented in Alzheimer...
ObjectivesTo investigate the association between cognitive decline and cortical atrophy in individua...
Background/Aims: To evaluate whether visual assessment of medial temporal lobe atrophy (vaMTA) can p...
Objectives: To investigate whether medial temporal lobe atrophy predicted outcome in patients with m...
Objective: To determine if baseline measurements of cerebral atrophy and severity of white matter hy...
OBJECTIVE: A large cohort of subjects with mild cognitive impairment (MCI) was categorized into tert...
Objective: To assess the relationship between MRI-derived changes in whole-brain and ventricular vol...
OBJECTIVE: To assess the relationship between MRI-derived changes in whole-brain and ventricular vol...
OBJECTIVE: To identify cognitively normal individuals at risk of Alzheimer disease (AD) based on cer...
BACKGROUND: Symptoms of memory loss are a common complaint within the general population and a frequ...
Background: Individuals diagnosed as having mild cognitive impairment (MCI) have a high likelihood o...
Objective: To estimate rates of progression from mild cognitive impairment (MCI) to dementia and of ...
Objectives: To investigate the association between cognitive decline and cortical atrophy in individ...
OBJECTIVE: To quantify the regional and global cerebral atrophy rates and assess acceleration rates ...
Objective: Mild behavioral impairment (MBI) is a neurobehavioral syndrome characterized by later lif...
Background: While acceleration in age-related cerebral atrophy has been well documented in Alzheimer...
ObjectivesTo investigate the association between cognitive decline and cortical atrophy in individua...
Background/Aims: To evaluate whether visual assessment of medial temporal lobe atrophy (vaMTA) can p...
Objectives: To investigate whether medial temporal lobe atrophy predicted outcome in patients with m...
Objective: To determine if baseline measurements of cerebral atrophy and severity of white matter hy...